Accessibility Menu
MediPharm Labs Stock Quote

MediPharm Labs (OTC: MEDIF)

$0.05
(2.4%)
+0.00
Price as of October 22, 2025, 3:25 p.m. ET

KEY DATA POINTS

Current Price
$0.05
Daily Change
(2.4%) +$0.00
Day's Range
$0.05 - $0.06
Previous Close
$0.05
Open
$0.05
Beta
0.76
Volume
8,334
Average Volume
148,989
Market Cap
23M
Market Cap / Employee
$0.05M
52wk Range
$0.04 - $0.09
Revenue
-
Gross Margin
0.32%
Dividend Yield
N/A
EPS
-$0.02
CAPs Rating
-
Industry
Pharmaceuticals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

MediPharm Labs Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
MEDIF-1.26%-91.5%-38.92%-97%
S&P+14.5%+93.32%+14.09%+132%

MediPharm Labs Company Info

MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$8.53M12.8%
Gross Profit$2.34M-10.8%
Gross Margin27.41%-7.3%
Market Cap$20.76M-6.9%
Market Cap / Employee$0.13M0.0%
Employees161-3.0%
Net Income-$2.72M-44.3%
EBITDA-$2.57M-114.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$7.59M-35.0%
Accounts Receivable$5.16M20.3%
Inventory6.9-2.1%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.01M-78.7%
Short Term Debt$0.39M-80.7%

Ratios

Q2 2025YOY Change
Return On Assets-15.68%4.4%
Return On Invested Capital-48.55%-5.4%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$2.09M-83.7%
Operating Free Cash Flow-$2.05M-87.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.590.510.930.6914.37%
Price to Sales0.690.570.930.67-16.03%
Price to Tangible Book Value0.600.520.950.7014.23%
Enterprise Value to EBITDA-9.98-8.49-134.52-5.50-47.54%
Return on Equity-23.7%-22.3%-16.2%-19.6%-22.05%
Total Debt$0.48M$0.27M$0.09M$0.40M-80.66%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.